Evidence map›Paper›PMID 37014056›Full record

ArticleeLife2023

Aggregating in vitro-grown adipocytes to produce macroscale cell-cultured fat tissue with tunable lipid compositions for food applications.

John Se Kit Yuen, Michael K Saad, Ning Xiang, Brigid M Barrick, Hailey DiCindio, Chunmei Li, Sabrina W Zhang, Miriam Rittenberg, Emily T Lew, Kevin Lin Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Preparation of COACS biomaterials science & engineering · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

John Se Kit YuenBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.ORCID 0000-0001-9854-1654
Michael K SaadBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Ning XiangBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Brigid M BarrickBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Hailey DiCindioBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Chunmei LiBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Sabrina W ZhangBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Miriam RittenbergBiological Engineering Department, MIT, Cambridge, United States.
Emily T LewBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Kevin Lin ZhangBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Glenn LeungBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
Jaymie A PietropintoBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.
David L KaplanBiomedical Engineering Department, Tissue Engineering Resource Center, Tufts University, Medford, United States.ORCID 0000-0002-9245-7774
Tufts University · USMoscow Institute of Thermal Technology · RU

Funding

Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
NIBIB NIH HHS P41 EB027062NIH HHS P41EB027062
6 · The paper itself

Abstract

We present a method of producing bulk cell-cultured fat tissue for food applications. Mass transport limitations (nutrients, oxygen, waste diffusion) of macroscale 3D tissue culture are circumvented by initially culturing murine or porcine adipocytes in 2D, after which bulk fat tissue is produced by mechanically harvesting and aggregating the lipid-filled adipocytes into 3D constructs using alginate or transglutaminase binders. The 3D fat tissues were visually similar to fat tissue harvested from animals, with matching textures based on uniaxial compression tests. The mechanical properties of cultured fat tissues were based on binder choice and concentration, and changes in the fatty acid compositions of cellular triacylglyceride and phospholipids were observed after lipid supplementation (soybean oil) during in vitro culture. This approach of aggregating individual adipocytes into a bulk 3D tissue provides a scalable and versatile strategy to produce cultured fat tissue for food-related applications, thereby addressing a key obstacle in cultivated meat production.

Indexed as

AdipocytesAdipose TissueAnimalsFatty AcidsMiceSwineFatty Acidscell biologycultivated fatcultivated meatcultured fatcultured meatlab-grown meatmouseregenerative medicinestem cellsSus scrofa domesticus (pig)

Identifiers

PMID37014056
PMCPMC10072877
OpenAlexW4362522900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.